Dados B3 › OIBR3 × VIVT3
OIBR3 × VIVT3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | OIBR3 | VIVT3 | year |
|---|---|---|---|
| ROE | -243.5% | 8.9% | 2021 |
| ROIC | -91.3%! | 6.7% | 2022 |
| ROA | 41.9%! | 4.5% | 2024 |
| Gross margin | -45.7%! | 43.9% | 2024 |
| EBIT margin | -61.5%! | 15.5% | 2024 |
| Net margin | 302.2%! | 10.0% | 2024 |
| Net debt/EBITDA | 11.73x | 0.55x | 2021 |
| Current ratio | 1.00x! | 0.94x | 2024 |
| Revenue growth (1y) | -25.3%! | 7.2% | 2024 |
| Revenue growth (5y CAGR) | -21.2%! | 4.8% | 2024 |
| Piotroski F-Score | 5/9! | 8/9 | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | OIBR3 | VIVT3 | year |
|---|---|---|---|
| P/E | 0.00x | 21.78x | 2024 × 2025 |
| P/B | — | 1.95x | 2024 × 2025 |
| EV/EBITDA | — | 5.95x | 2024 × 2025 |
| FCF yield | -352,559.1% | 8.4% | 2024 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:57 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:57 UTC. If this does not match /saude, you are reading a cached copy.